These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 32418288)

  • 1. Steroid-Responsive Encephalitis in Coronavirus Disease 2019.
    Pilotto A; Odolini S; Masciocchi S; Comelli A; Volonghi I; Gazzina S; Nocivelli S; Pezzini A; Focà E; Caruso A; Leonardi M; Pasolini MP; Gasparotti R; Castelli F; Ashton NJ; Blennow K; Zetterberg H; Padovani A
    Ann Neurol; 2020 Aug; 88(2):423-427. PubMed ID: 32418288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
    Bartiromo M; Borchi B; Botta A; Bagalà A; Lugli G; Tilli M; Cavallo A; Xhaferi B; Cutruzzulà R; Vaglio A; Bresci S; Larti A; Bartoloni A; Cirami C
    Transpl Infect Dis; 2020 Aug; 22(4):e13286. PubMed ID: 32279418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
    Gómez-Enjuto S; Hernando-Requejo V; Lapeña-Motilva J; Ogando-Durán G; Fouz-Ruiz D; Domingo-García J; Rodríguez-García E; Cemillán-Fernández CA
    Seizure; 2020 Aug; 80():157-158. PubMed ID: 32574838
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2.
    Zhang H; Xie C; Huang Y
    J Thorac Oncol; 2020 May; 15(5):e63-e64. PubMed ID: 32147577
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
    Nuño L; Novella Navarro M; Bonilla G; Franco-Gómez K; Aguado P; Peiteado D; Monjo I; Tornero C; Villalba A; Miranda-Carus ME; De Miguel E; Bogas P; Castilla-Plaza A; Bernad-Pineda M; García-Lorenzo E; Rodríguez-Araya T; Balsa A
    Ann Rheum Dis; 2020 Dec; 79(12):1659-1661. PubMed ID: 32606046
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
    Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
    [No Abstract]   [Full Text] [Related]  

  • 12. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
    Cingolani A; Tummolo AM; Montemurro G; Gremese E; Larosa L; Cipriani MC; Pasciuto G; Liperoti R; Murri R; Pirronti T; Cauda R; Fantoni M;
    Infection; 2020 Oct; 48(5):767-771. PubMed ID: 32642806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.
    Afshar H; Yassin Z; Kalantari S; Aloosh O; Lotfi T; Moghaddasi M; Sadeghipour A; Emamikhah M
    Mult Scler Relat Disord; 2020 Aug; 43():102216. PubMed ID: 32464585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
    Bhatnagar T; Murhekar MV; Soneja M; Gupta N; Giri S; Wig N; Gangakhedkar R
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):184-189. PubMed ID: 32362644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
    Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
    Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
    [No Abstract]   [Full Text] [Related]  

  • 16. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
    Zhang K; Tian M; Zeng Y; Wang L; Luo S; Xia W; Zhang X; Zha Y
    Complement Ther Med; 2020 Aug; 52():102473. PubMed ID: 32951723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 18. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
    Tadolini M; Codecasa LR; García-García JM; Blanc FX; Borisov S; Alffenaar JW; Andréjak C; Bachez P; Bart PA; Belilovski E; Cardoso-Landivar J; Centis R; D'Ambrosio L; Luiza De Souza-Galvão M; Dominguez-Castellano A; Dourmane S; Fréchet Jachym M; Froissart A; Giacomet V; Goletti D; Grard S; Gualano G; Izadifar A; Le Du D; Marín Royo M; Mazza-Stalder J; Motta I; Ong CWM; Palmieri F; Rivière F; Rodrigo T; Silva DR; Sánchez-Montalvá A; Saporiti M; Scarpellini P; Schlemmer F; Spanevello A; Sumarokova E; Tabernero E; Tambyah PA; Tiberi S; Torre A; Visca D; Zabaleta Murguiondo M; Sotgiu G; Migliori GB
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32457198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multifocal encephalitis as a neurological manifestation of COVID-19 infection].
    Serrano-Serrano B; López-Hernández N; Dahl-Cruz F; Elvira-Soler E; Díaz-Marín C
    Rev Neurol; 2020 Nov; 71(9):351-352. PubMed ID: 33085080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.